CHM color picture of the retina

Choroideremia Research Is Necessary to Help Prevent Blindness at an Early Age

June 16, 2020 Choroideremia is an X-linked, recessive, inherited retinal disorder that affects 1 in 50,000 individuals. X-linked refers to the X chromosome, which is one of the chromosomes that determines gender. Females receive an X chromosome from each parent; …

Oct

In-Depth Vision Evaluations & Research Updates for Retinal Diseases – Video Update

May 15, 2020 Yi-Zhong Wang, Ph.D., Director, Macular Function Laboratory, discusses visual function and imaging evaluation for patients with retinal diseases and his deep machine learning project in the video update below. This update is relevant for those interested in …

Pediatric patient with eye patch

Early Detection and Treatment for Pediatric Eye Conditions – Video Update

May 8, 2020 Reed Jost, Research Associate, shares the latest updates from the Crystal Charity Ball Pediatric Vision Laboratory at the Retina Foundation. In the videos below, he will share information on different research projects for improving early detection as …

Retina Foundation Logo For Facebook

COVID-19 Guidelines For Retina Foundation Staff and Visitors

April 29, 2020 The Retina Foundation has implemented ongoing safeguards, in response to the COVID-19 pandemic, to ensure the health and safety of all staff and visitors. These procedures will continue until further notice.   STAFF AND VISITOR RISK MANAGEMENT …

2019retinafdn 016 (reduced)

Developing a Treatment for Age-Related Macular Degeneration – Video Update

April 24, 2020 In this video, Tim Catchpole, Ph.D., Senior Research Associate, Molecular Ophthalmology Laboratory, provides a brief overview of age-related macular degeneration (AMD) and shares how we are developing a novel treatment for AMD. Should you have any questions, …

2019retinafdn 771 (reduced)

Investigating the Impact of Lazy Eye on Reading Speed and Motor Skills in Children – Video Update

April 17, 2020 This video was created to share with our supporters the various ways we are investigating the impact of lazy eye on reading speed and motor skills in children. Should you have any questions, please call us at 214.363.3911 …

2019retinafdn 016 (reduced)

Retina Foundation 20/20 Video Research Updates

The Retina Foundation is pleased to share 20/20 video updates as we continue to move forward with our cutting-edge research, reading, planning experiments, analyzing data, and drafting new grant proposals as we telecommute. Introduction Video by Dr. Karl Csaky, CEO …

Drew Brees Cropped

Join Drew Brees and the Retina Foundation for the Third Annual Visionary Luncheon – March 4, 2020

Drew Brees, Super Bowl-winning quarterback for the New Orleans Saints and Texas native, will be the featured speaker for the 2020 Visionary Luncheon benefiting the Retina Foundation of the Southwest on Wednesday, March 4, 2020. As much pride as Brees takes in …

Img 1764

Promising results from ongoing Phase 1/2 clinical trial for X-linked retinitis pigmentosa (XLRP)

October 1, 2019 The Retina Foundation of the Southwest is one of four U.S. centers conducting a Phase 1/2 dose escalation, gene replacement trial for x-linked retinitis pigmentosa (XLRP). On September 26th, the clinical trial sponsor, Applied Genetic Technologies Corporation …

2019retinafdn 248

The Effectiveness of Therapeutic Drugs for AMD in the Laboratory

September 26, 2019 Ruvanthi Kularatne, Ph.D., is a Postdoctoral Fellow at the Retina Foundation of the Southwest, working under the direction of Karl Csaky, M.D., Ph.D., Managing & Medical Director. Dr. Kularatne has spent the past year evaluating the effectiveness …

Retina01large Copy

Introducing the Vision and Neurodevelopment Laboratory

August 15, 2019 We are pleased to announce Krista Kelly, Ph.D. as Director of the Vision and Neurodevelopment Laboratory! Dr. Krista Kelly received her Ph.D. from York University in 2014 before joining the Retina Foundation of the Southwest as a …

2019retinafdn 068

Measuring the Release of A Therapeutic Drug in a Controlled Lab Setting

August 2, 2019 Age-related macular degeneration (AMD) has multiple stages of progression. The “dry” form is characterized by yellow deposits called drusen, that grow in size and number, leading to dimmed or distorted vision. There are currently no treatments for …

2019retinafdn 659 Eye Chart

Retina Foundation Asks Kids to ‘Just Dance’ for Research Study

July 31, 2019 The Retina Foundation is an international leader in research on lazy eye, the most common cause of visual impairment in children. A new treatment we are working on in collaboration with Mayo Clinic has the goal of …

Gene Therapy

Gene Therapy Trial for Choroideremia

July 23, 2019 In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the efficacy of gene therapy in patients with choroideremia. This late stage trial is based on early Phase …

2019retinafdn 479 (reduced)

FFB Pledges $300,000 to Support Dr. Yi-Zhong Wang’s Artificial Intelligence/ Deep Machine Learning Project

July 19, 2019 Yi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge …